Invokana 100 mg 30 tabletten
Oral blood glucose lowering agent. Selectively inhibits the sodium/glucose cotransporter 2 (SGLT2) in the kidney. Weakly inhibits SGLT1 in the intestine.
Active ingredients: Each tablet contains canagliflozin hemihydrate, equivalent to 100 mg canagliflozin.
Additional ingredients: Each tablet contains 39.2 mg lactose, Microcrystalline cellulose, Hydroxypropyl cellulose, Croscarmellose sodium, Magnesium stearate, Poly(vinyl alcohol), Titanium dioxide (E171), Macrogol 3350, Talc, Iron oxide yellow (E172)